Pharmaceutical Company CEO Developing $100 Alternative To EpiPen After 'Shameful' Price Hike
September 4, 2016
Mark Baum, CEO of Imprimis Pharmaceuticals who previously came out with a $1 alternative to Martin Shkreli's AIDS drug after 5000% price hike, is now going to take on Mylan and is plotting to offer a $100 EpiPen alternative.
Mark Baum / Imprimis Pharmceuticals
Baum believes the relentless EpiPen price hikes are "shameful" and plans to have a compounded version of the allergy treatment by the end of the year.
"I don't need to make $19 million a year," Baum said, referring to the big pay package Mylan's CEO Heather Bresch took home last year.
"Tonight when I go home I'm going to eat a nice piece of fish and the fish I eat isn't any better or worse than what she is going to eat."
Click Here For The Most Popular On Sunny Skyz
This Guy's Card Trick Is So Good It Makes Penn MAD!
This Restaurant Only Hires Servers With Dementia So You Never Know What You're Getting
Tim Tebow's Act Of Kindness At A Baseball Game Will Warm Your Heart
This Hairy Chest Women's Swimsuit Is Selling Like Crazy
If You've Never Seen A Husky Without Body Hair, Here You Go
Wendy's Got Into A Hilarious Sign Battle With Pure Water
This Guy's Card Trick Is So Good It Makes Penn MAD!
Disabled Former Marine Sees His Grandson In Uniform For The First Time
Dad Loses Son's Lunchbox And Brings Home A Toolbox. Mom's Not Impressed, Then She Flips It Over
This Is What Happened When A Lost Kitten Strayed Into A Raccoon Feeding Area
Baby Elephant Gets Frightened By Goat, Screams And Runs For Its Life
